Medical Blog About Treatment Abroad

Hepatocellular carcinoma (HCC) is the most widespread form of liver cancer, and it is believed to be one of the leading causes of cancer-related deaths on earth. The sixth most common malignancy and the third most common cause of death due to cancer in the world is liver cancer. The most common of these is hepatocellular carcinoma...

Prostate cancer is the second most common cancer diagnosis among men and remains one of the leading causes of cancer-related deaths worldwide. According to GLOBOCAN 2018, more than 1,276,000 new cases were reported globally, with a particularly high incidence in developed countries. The risk of developing prostate...

Breast cancer (BCa) statistics from the World Health Organization reports that more than 2.3 million women were diagnosed with this disease in 2022. BCa is among the most common and challenging diseases affecting women all around the world. And over 670,000 deaths were attributed to it that year. But there's reason for hope. Treatment has...

The liver is the body's laboratory – it filters blood and performs hundreds of vital functions. Unfortunately, this makes it vulnerable to cancer cells: they travel through the bloodstream from the primary tumor and settle there, forming secondary liver cancer called hepatic metastases. According to the results of large-scale studies, colorectal...

Dendritic cell therapy is a form of cancer immunotherapy that utilizes the body's own immune system to fight cancer cells. It is considered a promising approach for patients with various cancers, including colon cancer. Regarding the latter, it is unfortunate, but this disease is one of the most prevalent malignancies worldwide. According to the 2020...

The fast-growing stem cell biology has turned modern medicine upside down, providing new ways of thinking about how to cure the previously considered incurable diseases. The special property of stem cells to promote tissue regeneration and convert to different types of tissues has provided the basis for new stem cell-based solutions...

The second most common cancer diagnosis in men and the fifth cause of cancer deaths all over the world is prostate cancer. GLOBOCAN 2018 reports that the number of new cases was 1,276,106 cases worldwide, with the main increase in developed countries. The mortality and the incidence are closely associated with age, and the rates...

Cancer remains far too common across Europe. In 2022 alone, there were approximately 4.47 million new cancer diagnoses – that's nearly one in four people up to age 75 developing cancer in their lifetime. This scale of disease highlights why blending integrative oncology with robust, conventional cancer care has become essential...